VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 424 filers reported holding VANECK VECTORS ETF TR in Q4 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $496,000 | +9.0% | 15,488 | +0.3% | 0.15% | -3.2% |
| Q3 2021 | $455,000 | -12.2% | 15,435 | +1.3% | 0.16% | -13.3% |
| Q2 2021 | $518,000 | +11.4% | 15,235 | +6.6% | 0.18% | -1.1% |
| Q1 2021 | $465,000 | -7.4% | 14,295 | +2.5% | 0.18% | -11.2% |
| Q4 2020 | $502,000 | +40.2% | 13,945 | -0.4% | 0.20% | +26.5% |
| Q3 2019 | $358,000 | 0.0% | 14,000 | 0.0% | 0.16% | -29.6% |
| Q2 2019 | $358,000 | +14.0% | 14,000 | 0.0% | 0.23% | +3.1% |
| Q1 2019 | $314,000 | +6.4% | 14,000 | 0.0% | 0.22% | -9.0% |
| Q4 2018 | $295,000 | -27.5% | 14,000 | -36.4% | 0.24% | -18.9% |
| Q3 2018 | $407,000 | -17.1% | 22,000 | 0.0% | 0.30% | -12.0% |
| Q2 2018 | $491,000 | +1.4% | 22,000 | 0.0% | 0.34% | -5.0% |
| Q1 2018 | $484,000 | -5.3% | 22,000 | 0.0% | 0.36% | -7.7% |
| Q4 2017 | $511,000 | +122.2% | 22,000 | +120.0% | 0.39% | +108.0% |
| Q3 2017 | $230,000 | +4.1% | 10,000 | 0.0% | 0.19% | +1.1% |
| Q2 2017 | $221,000 | – | 10,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |